Wells Fargo’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
284,931
+66,847
| +31% | +$599K | ﹤0.01% | 2736 |
|
|
2025
Q1 | $1.64M | Buy |
218,084
+113,921
| +109% | +$854K | ﹤0.01% | 2958 |
|
|
2024
Q4 | $783K | Buy |
104,163
+36,166
| +53% | +$272K | ﹤0.01% | 3432 |
|
|
2024
Q3 | $517K | Sell |
67,997
-4,447
| -6% | -$33.8K | ﹤0.01% | 3602 |
|
|
2024
Q2 | $448K | Buy |
72,444
+9,787
| +16% | +$60.5K | ﹤0.01% | 3644 |
|
|
2024
Q1 | $318K | Buy |
62,657
+6,818
| +12% | +$34.6K | ﹤0.01% | 3827 |
|
|
2023
Q4 | $334K | Sell |
55,839
-136,351
| -71% | -$817K | ﹤0.01% | 3775 |
|
|
2023
Q3 | $1.36M | Sell |
192,190
-63,491
| -25% | -$450K | ﹤0.01% | 2877 |
|
|
2023
Q2 | $1.8M | Buy |
255,681
+71,732
| +39% | +$505K | ﹤0.01% | 2843 |
|
|
2023
Q1 | $1.53M | Buy |
183,949
+174,123
| +1,772% | +$1.45M | ﹤0.01% | 2891 |
|
|
2022
Q4 | $113K | Sell |
9,826
-7,421
| -43% | -$85.2K | ﹤0.01% | 4192 |
|
|
2022
Q3 | $216K | Sell |
17,247
-5,425
| -24% | -$67.9K | ﹤0.01% | 3935 |
|
|
2022
Q2 | $240K | Sell |
22,672
-132,280
| -85% | -$1.4M | ﹤0.01% | 3939 |
|
|
2022
Q1 | $2.52M | Sell |
154,952
-61,242
| -28% | -$996K | ﹤0.01% | 2907 |
|
|
2021
Q4 | $3M | Buy |
216,194
+15,423
| +8% | +$214K | ﹤0.01% | 2914 |
|
|
2021
Q3 | $2.89M | Sell |
200,771
-160
| -0.1% | -$2.3K | ﹤0.01% | 3199 |
|
|
2021
Q2 | $3.18M | Sell |
200,931
-868
| -0.4% | -$13.7K | ﹤0.01% | 3131 |
|
|
2021
Q1 | $2.05M | Sell |
201,799
-270,578
| -57% | -$2.75M | ﹤0.01% | 3458 |
|
|
2020
Q4 | $3.52M | Buy |
472,377
+3,691
| +0.8% | +$27.5K | ﹤0.01% | 3014 |
|
|
2020
Q3 | $1.61M | Sell |
468,686
-11,436
| -2% | -$39.3K | ﹤0.01% | 3428 |
|
|
2020
Q2 | $2.29M | Buy |
480,122
+387,709
| +420% | +$1.85M | ﹤0.01% | 3122 |
|
|
2020
Q1 | $184K | Sell |
92,413
-52,306
| -36% | -$104K | ﹤0.01% | 4569 |
|
|
2019
Q4 | $500K | Sell |
144,719
-44,863
| -24% | -$155K | ﹤0.01% | 4268 |
|
|
2019
Q3 | $544K | Buy |
189,582
+6,163
| +3% | +$17.7K | ﹤0.01% | 4207 |
|
|
2019
Q2 | $695K | Buy |
183,419
+98,038
| +115% | +$371K | ﹤0.01% | 4065 |
|
|
2019
Q1 | $696K | Buy |
85,381
+19,386
| +29% | +$158K | ﹤0.01% | 4094 |
|
|
2018
Q4 | $532K | Sell |
65,995
-1,759
| -3% | -$14.2K | ﹤0.01% | 4173 |
|
|
2018
Q3 | $517K | Buy |
67,754
+4,628
| +7% | +$35.3K | ﹤0.01% | 4313 |
|
|
2018
Q2 | $361K | Sell |
63,126
-4,926
| -7% | -$28.2K | ﹤0.01% | 4562 |
|
|
2018
Q1 | $324K | Buy |
68,052
+15,403
| +29% | +$73.3K | ﹤0.01% | 4558 |
|
|
2017
Q4 | $258K | Sell |
52,649
-44,022
| -46% | -$216K | ﹤0.01% | 4677 |
|
|
2017
Q3 | $507K | Buy |
96,671
+32,530
| +51% | +$171K | ﹤0.01% | 4218 |
|
|
2017
Q2 | $356K | Sell |
64,141
-15,962
| -20% | -$88.6K | ﹤0.01% | 4308 |
|
|
2017
Q1 | $673K | Sell |
80,103
-38,330
| -32% | -$322K | ﹤0.01% | 3966 |
|
|
2016
Q4 | $750K | Buy |
118,433
+90,103
| +318% | +$571K | ﹤0.01% | 3832 |
|
|
2016
Q3 | $125K | Buy |
28,330
+6,500
| +30% | +$28.7K | ﹤0.01% | 4577 |
|
|
2016
Q2 | $62K | Sell |
21,830
-14,578
| -40% | -$41.4K | ﹤0.01% | 4906 |
|
|
2016
Q1 | $103K | Buy |
36,408
+4,199
| +13% | +$11.9K | ﹤0.01% | 4635 |
|
|
2015
Q4 | $332K | Sell |
32,209
-13,976
| -30% | -$144K | ﹤0.01% | 4024 |
|
|
2015
Q3 | $526K | Sell |
46,185
-6,238
| -12% | -$71K | ﹤0.01% | 3800 |
|
|
2015
Q2 | $783K | Buy |
52,423
+10,767
| +26% | +$161K | ﹤0.01% | 3728 |
|
|
2015
Q1 | $376K | Buy |
41,656
+3,428
| +9% | +$30.9K | ﹤0.01% | 4018 |
|
|
2014
Q4 | $465K | Buy |
38,228
+5,449
| +17% | +$66.3K | ﹤0.01% | 3903 |
|
|
2014
Q3 | $321K | Buy |
32,779
+11,705
| +56% | +$115K | ﹤0.01% | 4063 |
|
|
2014
Q2 | $269K | Sell |
21,074
-18,436
| -47% | -$235K | ﹤0.01% | 4158 |
|
|
2014
Q1 | $418K | Buy |
39,510
+13,454
| +52% | +$142K | ﹤0.01% | 3913 |
|
|
2013
Q4 | $198K | Sell |
26,056
-7,846
| -23% | -$59.6K | ﹤0.01% | 4193 |
|
|
2013
Q3 | $247K | Buy |
33,902
+24,751
| +270% | +$180K | ﹤0.01% | 4067 |
|
|
2013
Q2 | $14K | Buy |
+9,151
| New | +$14K | ﹤0.01% | 4865 |
|